세계의 단백질 A 수지 시장 : 제품 유형, 용도, 최종 사용자별 예측(2025-2030년)

The Protein A Resin Market was valued at USD 1.42 billion in 2023, expected to reach USD 1.61 billion in 2024, and is projected to grow at a CAGR of 13.18%, to USD 3.40 billion by 2030.

Protein A resin is a critical component in the biopharmaceutical industry, primarily used for the purification of monoclonal antibodies through affinity chromatography. The necessity of Protein A resin arises from the increasing demand for monoclonal antibodies in therapeutics due to their efficacy in treating various diseases, including cancer and autoimmune disorders. Key applications of Protein A resin include downstream processing in biomanufacturing to ensure the high purity of the final product. End-users mainly encompass pharmaceutical companies, academic research institutes, and contract research and manufacturing organizations.

The market for Protein A resin is driven by the growing biopharmaceutical sector, advancements in antibody manufacturing technologies, and increased funding in healthcare research. Furthermore, the shift towards biologics and biosimilars is anticipated to amplify its demand. However, high production costs, the availability of alternative purification technologies, and the resin's limited lifespan pose significant constraints. Additionally, regulatory challenges in biopharmaceutical manufacturing could impede market expansion.

Opportunities lie in developing reusable and cost-effective Protein A resin, enhancing resin binding capacity, and expanding applications beyond monoclonal antibody purification to other biologics. Innovations such as the use of synthetic biology to develop engineered resins that improve purification efficiency or decrease costs are promising avenues for business growth. Collaborative research efforts between resin manufacturers and biopharmaceutical companies could yield these advancements, capitalizing on the increasing trend of strategic partnerships in the industry.

The market's nature is highly competitive, with a few major players dominating due to high entry barriers related to technological expertise and capital investment. Companies that focus on R&D to improve product quality and efficiency, driven by advancements in biotechnology, will likely maintain a competitive edge. To capitalize on market opportunities, stakeholders should invest in expanding their product portfolio, enhance customer education on the benefits of innovative resins, and collaborate closely with regulatory bodies to navigate compliance challenges. Overall, innovation in manufacturing processes and strategic partnerships are pivotal to navigating this dynamic market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein A Resin Market

The Protein A Resin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing usage in immunoprecipitation of proteins, protein complexes or antigens
  • Rising applications of protein A resins in biomanufacturing and therapeutic antibodies
  • Potential demand of protein A resins for disposable pre-packed columns
• Market Restraints
  • Concern associated with the production of protein A resins
• Market Opportunities
  • Ongoing numerous contract manufacturing and contract research organizations
  • Surging demands of biosimilars to treat certain types of cancers and side effects
• Market Challenges
  • Dearth of skilled and experienced professionals across the world

Porter's Five Forces: A Strategic Tool for Navigating the Protein A Resin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein A Resin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein A Resin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein A Resin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein A Resin Market

A detailed market share analysis in the Protein A Resin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein A Resin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein A Resin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein A Resin Market

A strategic analysis of the Protein A Resin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein A Resin Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agarose Bead Technologies S.L., Agilent Technologies, Inc., Avantor, Inc., Bio-Rad Laboratories, Inc., Bio-Works Technologies AB, Biokal, Cytiva, GALAK Chromatography Technology Co., Ltd, General Electric Company, GenScript Biotech Corporation, IPSUM LIFESCIENCES LLP, JSR Life Sciences, LLC, Kaneka Corporation, Merck KGaA, Orochem Technologies Inc., Promega Corporation, Purolite Corporation by Ecolab Inc., Repligen Corporation, Sartorius AG, Thermo Fisher Scientific, Inc., Tosoh Corporation, and UBPBio, LLC.

Market Segmentation & Coverage

This research report categorizes the Protein A Resin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Agarose-based Protein A, Glass/Silica-based Protein A, and Organic Polymer-based Protein A.
• Based on Type, market is studied across Natural Protein A and Recombinant Protein A.
• Based on Application, market is studied across Antibody Purification, Immunoprecipitation, and Vaccine Development.
• Based on End-User, market is studied across Academic Research Institutes, Diagnostic Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing usage in immunoprecipitation of proteins, protein complexes or antigens
    • 5.1.1.2. Rising applications of protein A resins in biomanufacturing and therapeutic antibodies
    • 5.1.1.3. Potential demand of protein A resins for disposable pre-packed columns
  • 5.1.2. Restraints
    • 5.1.2.1. Concern associated with the production of protein A resins
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing numerous contract manufacturing and contract research organizations
    • 5.1.3.2. Surging demands of biosimilars to treat certain types of cancers and side effects
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled and experienced professionals across the world
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein A Resin Market, by Product

• 6.1. Introduction
• 6.2. Agarose-based Protein A
• 6.3. Glass/Silica-based Protein A
• 6.4. Organic Polymer-based Protein A

7. Protein A Resin Market, by Type

• 7.1. Introduction
• 7.2. Natural Protein A
• 7.3. Recombinant Protein A

8. Protein A Resin Market, by Application

• 8.1. Introduction
• 8.2. Antibody Purification
• 8.3. Immunoprecipitation
• 8.4. Vaccine Development

9. Protein A Resin Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Diagnostic Laboratories
• 9.4. Pharmaceutical & Biopharmaceutical Companies

10. Americas Protein A Resin Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Protein A Resin Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Protein A Resin Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Future Fields raises USD 11.2m to scale up fruit flies for recombinant protein production
  • 13.3.2. Bright Biotech raises USD 3.2m for plant based recombinant proteins
  • 13.3.3. Purolite and Repligen announce ligand partnership
  • 13.3.4. Thermo Fisher Scientific completes acquisition of PeproTech, a leader in recombinant proteins
  • 13.3.5. SSPC to work with five biopharma companies on antibody medicine research
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. Agarose Bead Technologies S.L.
• 3. Agilent Technologies, Inc.
• 4. Avantor, Inc.
• 5. Bio-Rad Laboratories, Inc.
• 6. Bio-Works Technologies AB
• 7. Biokal
• 8. Cytiva
• 9. GALAK Chromatography Technology Co., Ltd
• 10. General Electric Company
• 11. GenScript Biotech Corporation
• 12. IPSUM LIFESCIENCES LLP
• 13. JSR Life Sciences, LLC
• 14. Kaneka Corporation
• 15. Merck KGaA
• 16. Orochem Technologies Inc.
• 17. Promega Corporation
• 18. Purolite Corporation by Ecolab Inc.
• 19. Repligen Corporation
• 20. Sartorius AG
• 21. Thermo Fisher Scientific, Inc.
• 22. Tosoh Corporation
• 23. UBPBio, LLC